Hair cells, the sensory receptors of the auditory, vestibular, and lateral-line organs, may be damaged by a number of agents including aminoglycoside antibiotics and severe overstimulation.
In the avian cochlea, lost hair cells can be replaced by regeneration
These new hair cells appear to be derived from a support cell precursor which is stimulated to divide by events associated with hair cell loss. Little is known about the timing and sequencing of events leading to new hair cell production.
In this study cell cycle-associated events in the avian cochlea were analyzed at early and late time intervals following a single high dose of gentamicin.
This single dose protocol has been shown to consistently result in extensive morphological damage and hair cell loss in the proximal region of the cochlea while sparing a morphologically undamaged distal cochlear region. This allowed for the differential analysis of the underlying support cell populations with respect to local hair cell loss. Three cell cycle associated markers were used to evaluate which cells entered and progressed through the cell cycle: statin, a G, associated nuclear marker; proliferating cell nuclear antigen (PCNA), a G,, S and G, associated marker; and 5bro-modeoxyuridine (BrdU), an S phase associated marker. Using these markers we found evidence for reversible changes in cell cycle status throughout the cochlea, while progression through S phase and mitosis was restricted to the region of the cochlea which sustained hair cell loss. [Key words: gentamicin, cochlea, hair cell regeneration, cell cycle, proliferating cell nuclear antigen (PCNA), 5-bromodeoxyuridine (BrdlJ), statin]
Hair cells, the sensory receptors of the auditory, vestibular, and lateral-line organs, may be damaged by a number of agents including aminoglycoside antibiotics and severe overstimulation. Previous studies have demonstrated that new hair cell production occurs throughout life in the auditory and vestibular epithelium in fish and amphibians, and in avian vestibular end organs (Corwin, 1985; Jorgensen and Mathiesen, 1988; Popper and Hoxter, 1990; Presson and Popper, 1990; Roberson et al., 1992) . Analogous ongoing production of auditory hair cells during postembryonic life does not appear to occur in avian and mammalian Recei ved Oct. 4, 1994; revised Dec. 30, 1994; accepted Jan. 1 I, 1994 However, after trauma-induced hair-cell death, lost hair cells can be replaced in the avian auditory sensory epithelium by regeneration (Cotanche, 1987; Cruz et al., 1987; Corwin and Cotanche, 1988; Ryals and Rubel, 1988) .
Several recent investigations have focused on identifying the precursor cells for new hair cells in the avian inner ear. Potential hair cell precursors include supporting cells, embryonic-like neuroepithelial cells and cells located immediately adjacent to the sensory epithelium (Girod et al., 1989; Raphael, 1992; Weisleder and Rubel, 1993; Stone and Cotanche, 1994; Tsue et al., 1994b) . The preponderance of the evidence suggests that new hair cells are primarily derived from a support cell precursor which is stimulated to divide by events associated with the loss of hair cells. Little is known about the cellular events that trigger this proliferation and previous studies have not addressed the timing and sequencing of events in the sensory epithelial cell populations as the cells are stimulated to enter and progress through the cell cycle.
In this study we looked at cell cycle associated events in the avian cochlea at early and late time intervals following gentamicin induced damage of the auditory epithelium. A single high dose of gentamicin, previously shown to cause a consistent amount and pattern of hair cell loss was used to initiate the regenerative events (Janas et al., 1994) . The resulting damage pattern consisted of extensive morphological damage and hair cell loss in the proximal region of the cochlea and a morphologically undamaged distal cochlear region, allowing for differential analysis of the underlying support cell populations. Three cell cycle associated markers were used to evaluate which cells entered and progressed through the cell cycle: statin, a G, associated nuclear marker; proliferating cell nuclear antigen (PCNA), a G,, S and G, associated marker; and 5-bromodeoxyuridine (BrdU), an S phase associated marker (Gratzner, 1982; Wang, 1985a; Bravo et al., 1987) . Using these markers we found evidence for reversible changes in cell cycle status throughout the cochlea, while progression through S phase and mitosis was restricted to the region of the cochlea which sustained hair cell loss.
A preliminary report of these data has been presented (Bhave et al., 1994) . Gentamicin injection Three-day-old chicks were given a single subcutaneous dose of gentamicin sulfate (250 mg/kg; Lyphomed, Deerfield, IL). Age-matched control chicks received no drug injections. The chicks were divided into groups based on the length of survival following gentamicin injection: 1, 3, 5, 7, and 20 d groups. The number of animals in each experimental group is listed in Tables l-3 .
Materials and Methods

Subjects
Bromodeoxyuridine injections Chicks in the short term post-BrdU survival groups received injections of the thymidine analog BrdU following different periods of recovery after gentamicin injection to assess the number, timing and position of cells entering S phase. A single series of three intraperitoneal injections of BrdU (100 mglkg; Sigma, St. Louis, MO) were given 4 hr apart on day 1, 3, 5, or 7 after gentamicin injection. BrdU injections were initiated at the same time of day for each animal. Age-matched control animals corresponding to the 3 and 5 d post-gentamicin injection groups also received BrdU, but no gentamicin. Chicks were sacrificed 24 hr after the first BrdU injection.
To determine the fate of cells that incorporate BrdU following injections at 5 d after gentamicin treatment, a long term post-BrdU group of chicks was given the same series of BrdU injections as described above on day 5 and then allowed to recover for 15 d. Age-matched control animals received BrdU injections, but no gentamicin.
Tissue preparation
Scanning electron microscopy.
Scanning electron microscopy was performed on cochleas from two birds from each post-gentamicin treatment group (1, 3, 5, and 20 d) and from each of the age-matched control groups. Following euthanasia, microdissection of the ears was performed and the cochlear ducts were perfused with a fixative consisting of 2.5% glutaraldehyde, 1% paraformaldehyde, 0.1 M sucrose, 5 mM MgSO, in phosphate-buffered saline (PBS, pH 7.4). The temporal bones were immersion fixed overnight. Tissue was postfixed in 1% osmium tetroxide in PBS for 1 hr. After PBS washes, the tectorial membrane was dissected and the tissue was subjected to serial dehydration steps followed by critical point drying. Specimens were mounted on aluminum studs, coated with pure gold, and examined with a JEOL microscope (model JEM 6300F).
PCNA, statin, ancl BrdC/. For PCNA and statin analysis, the cochlear ducts were perfused with methanol-Carnoys fixative for 5 min. The temporal bones were then immersion fixed in the same fixative overnight at 4°C. Following alcohol rinses, the cochlear ducts were removed from the temporal bones, dehydrated in graded alcohols, cleared in methyl salicylate and paraffin embedded. Beginning at the proximal end, the entire cochlea was serially sectioned into 5 p.m thick tissue sections. Sets of seven sequentially cut tissue sections were collected at 600 pm intervals measured from the proximal end of the cochlea and the sections were mounted on chrome-alum-subbed slides. The first six slides from each set were immunostained for PCNA or statin in alternating order, while the seventh slide was stained with thionin in order to count the number of cells in each region.
For BrdU analysis the temporal bones were dissected in cold Hanks' buffered saline solution (HBSS). Most of the bone and cartilage surrounding each cochlear duct and the tegmentum vasculosum were removed. Cochlear ducts (still partially supported by the remaining bone) were placed in collagenase Type I (0.0007 gm/lO ml HBSS; Sigma) for 3 min, and tectorial membranes were removed. Cochleas were then rapidly rinsed in fresh HBSS and fixed in 4% paraformaldehyde (pH 7.4) for 20 min. Following PBS washes, cochleas were stored in PBS at 4°C prior to BrdU immunohistochemistry.
Immunohistochemistry
All the incubations were carried out at room temperature with PBS washes between steps unless otherwise stated.
PCNA und statin immunohistochemistry.
After deparaffinization and rehydration, endogenous peroxidase activity was blocked using 0.3% H202 for 10 min, followed by 0.1% Triton X 100, 0.5% BSA in PBS for 7 min and 4% normal horse serum for 45 min. Anti-PCNA monoclonal antibody 19A2 (1:4000 in 1% BSAIPBS; Coulter Immunology, Hialeah, FL) or anti-statin monoclonal antibody S44 (1:25,000 in 1% BSA/PBS; gift of E. Wang, Toronto, Canada) was incubated on the tissue sections in a moist chamber overnight at 4°C. In the case of 19A2, To detect BrdU-labeled cells, the protocol originally established by Raphael (1992) and modified by Stone and Cotanche (1994) for BrdU immunohistochemistry in cochlear whole-mounts was followed. Cochlear ducts were placed in 2 N HCl diluted in 0.05% Triton X-100 in PBS for 20 min at 37°C. Cochleas were then dissected from the remaining temporal bone. The tissue was placed in 0.05% hydrogen peroxide in PBS (pH 7.8) for 15 min and then 5% normal goat serum in 0.05% Triton X 100 in PBS. Table 3 . Mean BrdU levels (with SD) across the length of the basilar papilla in control and experimental chicks da& 1, 3, 5, 7, and 20
0 (0.37) 218 (133.7)** 1 (2.5) 27 (12.5)++ 3 (2.5) 3 (1.6) 2 (1.7) 22 (13.6)" 1 (0.9)
All 11 values derived from single factorial ANOVA comparison with control groups.
BrdlJ immunohistochemistry
analysis. Whole-mounts were examined on a Leica Axioplan microscope using Nomarski optics and a 100X objective.
The epithelium was compartmentalized along its length into 600 pm regions by measuring along the mid-width line of the epithelium starting at the proximal end and extending to the apical end. BrdUlabeled nuclei were counted within each 600 pm compartment.
Counts from the first two 600 pm compartments (o-1200 pm), corresponding to the morphologically damaged region, were combined to attain a value for the proximal region. Since the region between 1200 and 1800 pm typically represents the zone of transition between the morphologically damaged and undamaged portions of the epithelium, labeled cells within this region were not counted in order to minimize errors in assigning labeled cells to either the damaged or undamaged region. Counts from 1800 pm to the distal end were combined to attain a value for the distal region. In order to only count labeled cells within the sensory epithelium, great care was taken to strictly avoid focal planes at or below the level of the basilar membrane so as to exclude labeled tympanic border cells and stromal cells (Girod et al., 1989 The number of immunohistochemically positive nuclei in each segment was then converted into a density measure of nuclei per 100 pm of basilar membrane width. The three density measurements taken from each cross section were then combined and averaged to derive a single nuclear density measurement for each cell type in each cochlear cross section, Separate total nuclear density measurements were derived for hair cell and support cell nuclei using the corresponding thionin-stained slide. Finally, the percentage of PCNA and statin labeled nuclei for the hair cell layer and support cell layer was then calculated by dividing the immunostained nuclear density by the total nuclear density.
To verify the reproducibility of the analysis, 20 randomly selected sections from two animals underwent an additional blinded analysis by two independent observers and were also analyzed twice by the same observer.
No significant inter/intraobserver differences in resulting ceil counts were found (0.93, Spearman rank correlation). 
Control group
Scanning electron microscopy. The chick cochlea contains an elongated sickle shaped sensory epithelium (Fig. la) . As described by Takasaka and Smith (1971) , the proximal portion of the epithelium is narrow compared with the distal portion. The sensory epithelium is located between the superior fibrocartilaginous plate (convex side), where the nerve fibers enter and the inferior fibrocartilaginous plate (concave side). As viewed from above, hair cell surfaces form a hexagonal array at the lumenal surface of the epithelium. They are characterized by the presence of stereocilia with surrounding support cells containing numerous microvilli.
Light microscopy. As previously stated, the cross-sectional area of the normal sensory epithelium can be divided into three roughly equal segments; superior, middle, and inferior (Fig. 2) . The superior segment is the region resting on the superior fibrocartilaginous plate where the nerve enters while the inferior segment is bounded by the hyaline cells. Detailed description of the sensory epithelium of the avian basilar papilla (cochlea) can be found in the classic paper by Takasaka and Smith (1971) and has been reviewed more recently by Manley (1990) . The normal sensory epithelium consists of hair cells which are located at the lumenal surface and supporting cells which extend from the basilar membrane to the lumenal surface. The hair cells are characterized by the presence of stereocilia, a cuticular plate, dark staining cytoplasm, nuclei located just below the lumenal surface and cell membranes which do not contact the basilar membrane. Support cells are identifiable by their lighter staining cytoplasm and nuclei which are located nearer the basilar membrane (Girod et al., 1989) . During development the anlage of the sensory epithelium is a true pseudostratified epithelium. As found in developing neural epithelium, the nuclei of the proliferating cells translocate from the basement membrane to the luminal surface during the transition from S-phase to M-phase of the cell cycle (Katayama and Corwin, 1993) . Similarly, during hair cell regeneration M-phase nuclei are found near the luminal surface while S-phase nuclei are closer to the basement membrane in both the cochlea and the vestibular epithelium of birds (Raphael, 1992; Stone and Cotanche, 1994; Tsue et al., 1994b) . It is not known presently if the proliferating cell maintains contact with the basement membrane throughout the cell cycle and, if so, when differentiating regenerated hair cells loose this basal extension.
Statin label. Statin immunoreactivity is seen in the nucleus with the greatest concentration of staining around the periphery. In the chicken skin control statin expression was largely absent in the basal proliferating layer with increasing expression in the upper terminally differentiated epithelial layers. Chick striated muscle nuclei underlying the skin were also positive for statin. In the undamaged cochlea, statin expression by cells in the sensory epithelium was identifiable in an average of 71% of hair cells and 62% of support cells for the whole cochlea ( Fig. 3a,b PCNA label. PCNA immunostaining is detected as a granular pattern in the nucleus along with a more diffuse nucleoplasmic reaction product. In control tissue, PCNA staining was located at the base of the intestinal crypts and in the basal layer of the chick skin, In the control, undamaged cochlea, PCNA stained cells were rare. An average of 3% of the support cell population labeled for PCNA with a slight increase in PCNA labeling in the distal (2400 pm) region compared with the more proximal region ( Fig. 4a,b ; Table 2 ). No hair cells in any undamaged control cochleas were labeled for PCNA. Among other cochlear cell populations, scattered cells were PCNA labeled among the tegmentum vasculosum cells, tympanic border cells, hyaline cells, homogene cells, and the chondrocytes of the fibrocartilaginous plate.
BrdU label. Immunohistochemical staining of BrdU was identifiable as a stippled nuclear pattern. In the proximal end of the epithelium (o-1200 pm), no BrdU-labeled nuclei were detected in control animals ( Fig. 5a,b ; Table 3 ). In the distal end of the epithelium (1800 pm to the most distal pole) an average of one labeled nucleus per region was detected. Except for a single pair of labeled nuclei, the BrdU-labeled nuclei were present as single cells. Focusing through the whole-mount tissue demonstrated that the majority of labeled cells were present at mid-depth in the region containing support cell nuclei.
One day post-gentamicin Scanning electron microscopy. On postinjection day 1, the proximal O-400 pm of the sensory epithelium contained areas with swollen hair cells and rare hair cell loss while the rest of the epithelium appeared normal (see Fig. lb for damage at 3 d) .
Light microscopy. Cross sections at 600 p,m from the proximal end did not demonstrate any detectable loss of hair cells. This was consistent with the scanning microscopy findings which demonstrated that hair cell loss was confined to the proximal 400 pm region. Sections from the more distal intervals (1200 pm, 1800 pm, and 2400 km) also appeared normal.
Statin label. Statin label at the proximal 600 pm interval was detected in only 49% of hair cells as compared to 91% in the control group (Fig. 3c,d ; Table 1 ). Hair cell labeling in the rest of the epithelium demonstrated a small increase in statin label. Fifty percent of the support cells at the 600 pm interval labeled with statin, whereas 62% of support cells labeled in the controls. Statin labeling in the support cells from the more distal intervals was not significantly changed from controls. No hair cells were found to be PCNA labeled. Support cells in the proximal intervals, 600 pm and 1200 pm, demonstrated an increase in PCNA label (20% and 16%, respectively) compared with normal controls, while a lesser increase was found in the distal intervals 1800 km and 2400 pm (11% and 9%, respectively) ( Fig. 4c,d ; Table 2 ). While these values were consistently above control levels, none reached statistical significance.
BrdU label. On average, five BrdU-labeled nuclei were detected in the proximal, morphologically damaged region while no labeled nuclei were found in the distal, morphologically undamaged region of most animals in this group (Table 3) .
Three days post-gentamicin Scanning electron microscopy. By day 3 there was extensive morphological damage in the hair cell layer from the proximal tip to 1000-1200 pm from the proximal end; all hair cells in this region had been lost (Fig. lb,c) . Compared with the extensive morphological damage noted in the proximal end, a "marginal" zone in the mid-cochlea (1200-1800 Frn) demonstrated variable degrees of damage. Edematous hair cells with widening and blebbing of the stereocilia and support cells with increased surface areas were evident. The epithelium beyond the marginal zone (>1800 pm) remained morphologically normal in appearance.
Light microscopy. By 3 d post-gentamicin most of the hair cells were lost and the cytoarchitecture was severely disrupted in the proximal 600 pm interval. The epithelium was thinner than normal controls and there was considerable variation in support cell nuclear sizes. At 1200 pm, all short hair cells were lost, but a few tall hair cells were still present (Takasaka and Smith, 1971) . No visible hair cell loss, or disturbance of the normal cellular architecture was found at 1800 km and 2400 w Statin label. Statin labeling in the hair cells (Table la) was further reduced compared with the 1 d post-gentamicin group both for the remaining hair cells in the morphologically damaged 600 pm and 1200 p,rn intervals (6% and 4%, respectively) and for the hair cells in the morphologically undamaged distal region (5%). Statin labeling in support cells (Table lb) was similarly reduced in all regions (600 pm, 12%; 1200 pm, 18%; 1800 pm, 21%; 2400 pm, 35%).
PCNA label. No hair cells were found to be PCNA labeled. The number of PCNA labeled support cells was markedly increased compared to the 1 d post-gentamicin group in the proximal, morphologically damaged-regions 600 km and 1200 pm (25% and 35%, respectively) while the distal, morphologically undamaged regions 1800 pm and 2400 km demonstrated a more moderate increase (17% and 7%) ( Table 2) .
BrdV label. Compared with the 1 d post-gentamicin group, a dramatic increase in the number of BrdU-labeled cells was noted with an average of 218 labeled nuclei in the proximal, morphologically damaged end of the epithelium (Fig. 5c,d , insets; Table  3 ). In marked contrast, an average of only 1 labeled cell was found in the distal, morphologically undamaged end which did not differ from controls.
After the third day following gentamicin injection, it was common to see pairs of BrdU-labeled nuclei in the proximal, Five days post-gentamicin Scanning electron microscopy. By 5 d post-gentamicin injection, the morphologically damaged proximal region contained numerous newly regenerated hair cells with immature stereocilia bundles (Fig. Id) . The epithelium beyond the marginal zone still did not show any morphological signs of damage to the hair cell surfaces or stereocilia bundles.
Light microscopy. Total loss of hair cells in the 600 pm region was seen. The 1200 pm region again demonstrated significant hair cell loss but some hair cells were present in the superior segment. While it was difficult to identify new hair cells in the paraffin cross sections, the thickness of the epithelium appeared to be restored along with a shift in nuclei towards the lumenal surface. Interval sections at 1800 and 2400 km appeared morphologically normal.
Statin label. Mature hair cells at the proximal 600 Frn interval had been lost. Remaining hair cells at 1200 km demonstrated a small increase in statin labeling compared with 3 d (34%), but labeling was still significantly less than controls ( Fig. 3c,d ; Table  1 ). Hair cells at 1800 pm and 2400 pm demonstrated the same pattern of increase in statin labeling relative to the 3 d group (38% and 28% respectively). Support cells at the proximal 600 pm interval demonstrated a further reduction in statin label compared with the 3 d animals (6%). In contrast, support cells at the 1200 pm interval showed a slight increase in statin label compared with the 3 d post-gentamicin group (34%) while the more distally located support cells (1800 and 2400 pm) remained unchanged in the proportion showing positive staining for statin (41% and 30%, respectively).
PCNA label. At 5 d post-gentamicin, again, no hair cells were labeled with PCNA. Compared with PCNA expression at 3 d post-gentamicin, there was no further increase in support cell labeling at the 600 pm interval (33%) (Fig. 4c,d ; Table 2 ). However, a further increase in labeling was observed at the 1200 km interval (65%) corresponding to the marginal zone of damage and in the morphologically undamaged distal end at 1800 pm and 2400 pm (40% and 24%, respectively).
BrdlJ label. By 5 d post-gentamicin, the number of BrdUlabeled cells had fallen to an average of 27 in the proximal, morphologically damaged region of the epithelium (Fig. 5c,d ; Table 3 ). An average of only three unpaired, labeled nuclei were detected in the distal, morphologically undamaged region, which did not reliably differ from controls.
Seven days post-gentamicin Light microscopy.
By 7 d post-gentamicin numerous new hair cells were detected in the proximal 600 pm and 1200 pm intervals while the support cell cytoarchitecture appeared to be returning to normal. Hair cells and support cells at 1800 pm and 2400 pm appeared normal.
PCNA label. No PCNA labeled hair cells were detected. PCNA label in the support cells was reduced compared with the 5 d group across the entire length of the basilar papilla, but PCNA labeling was still elevated compared with the normal controls (Table 2) .
BrdU label. At 7 d post-gentamicin, the number of BrdUlabeled cells approached the control levels with an average of three labeled nuclei in the proximal region and an average of two labeled nuclei in the distal region of the epithelium (Table  3) . With the exception of one pair of cells, labeled nuclei in the distal morphologically undamaged region were not contiguous.
Twenty days post-gentamicin Scanning electron microscopy. The basilar papilla in the proximal morphologically damaged region at 20 d post-gentamicin injection demonstrated significant numbers of regenerated hair cells with mature appearing stereocilia bundles and restoration of the hexagonal pattern. The orientation of hair cell stereocilia bundles was not as uniform as in the normal sensory epithelium. Additionally, hair cells appeared to be farther apart with increased surface areas while the lumenal surfaces of the support cells appeared to have returned to their normal size.
Light microscopy. In the proximal 600 pm and 1200 pm intervals numerous new hair cells were detected. The morphology was similar to undamaged hair cells in normal controls. Hair cells were loosely arranged particularly in the superior segment. Support cell layer morphology appeared normal. Interval sections at 1800 pm and 2400 pm remained unchanged.
Statin label. By 20 d post-gentamicin, statin expression in hair cells throughout the cochlea approached the levels seen in normal control cochleas (65% and 92% at 600 pm and 1200 pm, respectively; 73% and 66% at 1800 pm and 2400 pm, respectively) (Table 1) . Similarly, statin expression in the support cell population throughout the cochlea approached normal control levels. PCNA label. Once again there were no PCNA positive hair cells. PCNA levels in the support cells remained elevated throughout the cochlea and were statistically equivalent to the 7 d animals (26% and 29% at 600 pm and 1200 pm; 40% and 14% at 1800 pm and 2400 pm) ( Table 2) .
BrdU label. The lack of paired BrdU labeled cells in the distal, morphologically undamaged region suggested that the few cells that had entered S phase did not pass through mitosis during the 24 hr following the initial BrdU injection. The alternative possibility, that one of the daughter cells had died and had been completely phagocytized, was considered unlikely during this short time period. To investigate the fate of the BrdU labeled cells in the distal, morphologically undamaged region, seven chicks were injected with BrdU at 5 d after gentamicin injection and were maintained for an additional 15 d prior to sacrifice (20 d post-gentamicin injection). Age-matched control animals (n = 3) consisted of chicks that did not receive gentamicin injection, but were given BrdU injections and sacrificed at the same time as chicks described above.
In 20 d control chicks an average of zero BrdU-labeled nuclei and an average of one labeled nucleus were found in the proximal and distal regions, respectively. In chicks that received a gentamicin injection an average of 22 labeled nuclei were detected in the proximal, morphologically damaged region while an average of 1 labeled nucleus was found in the distal, morphologically undamaged region (Table 3) . At 20 d, there were several sets of paired nuclei in the proximal, morphologically damaged region but only single labeled nuclei in the distal, morphologically undamaged region. In the distal region, none of the BrdU labeled nuclei appeared to belong to a hair cell. These results were qualitatively and quantitatively similar to the 5 d short term post-BrdU chicks for both regions. These findings suggest that the few cells in the undamaged region that incorporated BrdU on day 5 after gentamicin injection were arrested in a premitotic state and failed to divide in the 15 d period between BrdU injection and analysis.
Discussion
For hair cell regeneration to occur, a number of events must be regulated including stimulation of precursor cell proliferation, differentiation of daughter cells into hair cells, and inhibition of further proliferation among the precursor cells once hair cell repopulation has occurred. Recent studies have begun to investigate diffusible factors and candidate molecules that may trigger mitotic activity, but little is known regarding the events that precede mitotic activity (Lambert, 1994; Oesterle et al., 1994; Tsue et al., 1994a; Yamashita and Oesterle, 1994) . The purpose of this study was to further elucidate the temporal and spatial patterns of events that may regulate progression of precursor cells through the cell cycle following application of an ototoxic agent in the chick.
The cell cycle is traditionally divided into four "active" phases (G,, S, G,, and M) and a resting phase (G,,) . A number of checkpoints exist throughout the cell cycle to prevent cells from entering it or progressing beyond certain points; these checkpoints aid in regulating and synchronizing proliferation among cell populations (Hartwell, 1991; Nasmyth and Hunt, 1993) . In this study, three cell cycle-associated markers, statin, PCNA, and BrdU, were used to locate cycling sensory epithelial cells temporally and spatially.
Statin is a 57 kDa nuclear protein that is immunohistochemically detectable in quiescent cells in the G, phase and in terminally differentiated cells. Originally described by Wang (Wang, 1985a,b) , statin has been characterized as a phosphoprotein whose function is incompletely understood (Lee et al., 1992) . In vitro, induction of statin expression occurs during TGF-P induced quiescence of lymphoblastic cell lines and in astroglial cell line terminal differentiation (Fedoroff et al., 1990; Ignotz, 1992) . Conversely, as growth-arrested fibroblasts are induced to enter G,, statin expressionis lost (Wang and Lin, 1986; Ching and Wang, 1990; Pellicciari et al., 1991) . In vim, statin expression is decreased as quiescent liver cells are induced to proliferate in response to hepatectomy (Sandig et al., 1994) .
Proliferating cell nuclear antigen (PCNA) is a subunit of DNA polymerase delta (Bravo et al., 1987) . As such, its expression increases in late G, and S phase of the cell cycle when it is needed for DNA replication. Interpretation of PCNA as a proliferation marker is complicated by the existence of two forms of PCNA which are differentially affected by fixation (Bravo and Macdonald-Bravo, 1987) . In formalin-fixed tissue, a persistent form of PCNA can be detected which is not necessarily associated with proliferation.
In alcohol-fixed and methanol-Car- noys-fixed tissues, as used in this study, only the proliferationassociated form is retained and PCNA detection is associated with late G,, S, and early G, phases of the cell cycle (Bravo and Macdonald-Bravo, 1987; Galand and Degraef, 1989; Garcia et al., 1989) . Peak levels of PCNA do vary in different cell types and levels found in late S or early G2 phases of the cell cycle may be below the immunocytochemically detectable threshold (Takahashi and Caviness, 1993) .
BrdU, a thymidine analog, is incorporated into the new DNA strands during S phase of the cell cycle (Gratzner, 1982) . Once incorporated, BrdU is retained in DNA as it is passed to daughter cells following successive rounds of mitosis. In cochleas that are examined shortly after BrdU injection, BrdU labeling represents a "snapshot" of the cells that progressed through S phase during the time of BrdU injection. In cochleas that are examined long after BrdU injection, BrdU staining reveals the fate of cells which had gone through S phase around the time of BrdU injection.
In this study, chicks that did not receive gentamicin injection displayed high levels of statin expression and low levels of PCNA expression in all regions of the cochlear epithelium. In the case of the hair cells, PCNA labeling was nonexistent. These findings are consistent with previous studies that have detected little or no mitotic activity in the normal avian cochlea (Corwin and Cotanche, 1988; Ryals and Rubel, 1988; Oesterle and Rubel, 1993) . Following gentamicin injection, both hair cells and support cells throughout the cochlear epithelium underwent changes in their cell cycle status (Fig. 6) (Fig. 7) . Interestingly, these changes were detected prior to microscopic evidence of drug-induced morphological damage to the sensory epithelium. Also notable was the fact that changes in these two cell cycle markers were not confined to the proximal region, which was destined to demonstrate hair cell loss. Rather, support cells in the distal region, which did not sustain detectable in.jury following a single gentamicin injection, demonstrated delayed changes in statin and PCNA expression. However, evidence of support cell progression into S phase (BrdU incorporation) was detected only after hair cell loss occurred (3 d after gentamicin injection) and was restricted to the morphologically damaged, proximal epithelium (Fig. 6) . Furthermore, BrdU labeling decreased dramatically at 5 d after gentamicin injection. This decrease coincided with the appearance of new hair cells in the proximal epithelium.
In the distal region where the hair cell population remained intact, there was no identifiable increase in BrdU incorporation at any of the time points examined.
In parallel with the support cell population, hair cells denonstrated a decrease in statin expression with proximal hair cells preceding distal hair cells. Notably, no demonstrable PCNA exprcssion was found in hair cells at any time following gentamicin injection. This finding is consistent with previous studies that have examined short-term incorporation of S phase markers in the cochlear epithelium (Oesterle and Rubel, 1993; Stone and Cotanche, 1994) . These data provide further evidence that new hair cells do not arise from other hair cells but rather from the support cell population.
Comparison of the cell cycle associated markers in the proximal, morphologically damaged region with the distal, morphologically undamaged region provides evidence for a widespread direct or indirect response to gentamicin among cells of the cochlear epithelium.
With the loss of statin expression and increase in PCNA expression, support cells throughout the cochlea appear to be stimulated to leave G,, and progress to late G, (Figs.  6, 7) . Such a global response has not been previously described and may represent cellular changes that are mediated by gentamicin itself or by a diffusible factor. On the other hand, progression of support cells into S phase is restricted to the proximal morphologically damaged region. Thus, the stimulus for DNA replication must be localized to the region of morphological cellular damage and/or loss. One possible stimulus is the extrusion and loss of hair cells thereby altering cellular contacts (Cotanche, 19X7; Corwin et al., 199 I). While progression through S phase and mitosis effectively ceases by 7 d poatgentamicin, PCNA and stntin levels remain affected after 20 d. This suggests persistence of some stimulus or growth factor even after hair cell repopulation.
In the present study we also observed a very small number of BrdU labeled cells in the distal half of the cochleas of both control and gentamicin treated animals. The fate of these BrdU labeled cells in the distal, morphologically undamaged region was explored. In the proximal, morphologically damaged region, the BrdU data clearly show consistent production of paired cells. The evidence suggests that at least some of these paired cells are daughter cells which further implies that support cells are able to progress from S phase through mitosis within the 24 hr period from the first BrdU injection to sacrifice. Cell cycle times on this order have been previously described for chick cochlear support cells (Raphael, 1992; Stone and Cotanche, 1992 and is phagocytized. In the absence of evidence for efficient macrophage infiltration of the morphologically intact epithelium, it seems unlikely that the cells are phagocytized within the 24 hr following BrdU uptake. On the other hand, while G, arrest is an acknowledged phenomenon and, indeed, is felt to be a central mechanism for completion of DNA repair prior to mitosis, it is not typically associated with long term cell survival (Hartwell, 1991; O'Connor et al., 1993 
